FDA : Testosterone Products to Get Venous Blood Clot Warning
FDA : Testosterone Products to Get Venous Blood Clot Warning

FDA : Testosterone Products to Get Venous Blood Clot Warning

Washington, DC: In public announcement issued this week, the US Food and Drug Administration (FDA) states it is requiring manufacturers to include a general warning in the drug labeling of all testosterone products about the risk of blood clots in the veins.

The potential for venous blood clots is already included on labels for products as a possible consequence for the condition polycythemia, or an abnormal increase in the number of red blood cells, the agency announced Thursday.

As a result of increased reports of polycythemia, the FDA is requiring a change to “ensure this risk is described consistently” in all approved products.

Such products are approved for use in men who lack or have low testosterone levels associated with medical conditions, including genetic problems and chemotherapy.

The FDA adds that officials are continuing an evaluation of the possible risk of stroke, heart attack, and death in patients taking such drugs in relation to blood clots in patients’ arteries.

Agencies/Canadajournal




  • About News

    Web articles – via partners/network co-ordinators. This website and its contents are the exclusive property of ANGA Media Corporation . We appreciate your feedback and respond to every request. Please fill in the form or send us email to: [email protected]

    Check Also

    Brian Laundrie news: 'We're not wasting our time,' police commander says

    Brian Laundrie news: ‘We’re not wasting our time,’ police commander says

    VENICE, Fla. – Six days into the search for Brian Laundrie, police in North Port …

    Leave a Reply